Stock listing

TPEx:6535 Lumosa Therapeutics Co Ltd (順藥) 股價

Follow Lumosa Therapeutics Co Ltd into a list and get an email when it puts out news.

Share price · TPEX:6535

$75.90 TWD +0.30 (+0.4%)

Close on Oct 16, 2026

Lumosa Therapeutics Co Ltd logo
Ticker
TPEx:6535
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

LT3001 demonstrates functional improvements in patients with disabling acute ischemic stroke

Feb 6, 2026

Lumosa Therapeutics announces positive results from LT3001(intravenous odatroltide) Phase 2B clinical trial in acute ischemic stroke

Oct 28, 2025

Board Approved the Revised Exclusive Licensing Agreement for the Veterinary Analgesic

Aug 9, 2022

Board Approved the Binding Term Sheet for LT1001, a Long-acting Analgesic Injection, with a Pakistani Pharmaceutical Company

Aug 9, 2022

Board of Directors approved the Cancellation of Restricted Shares to Employees Stock Awards

Aug 9, 2022

Board of Directors approved the consolidated financial report for the second quarter of 2022

Aug 9, 2022

Board Approved the Amendments for the Exclusive Licensing Agreement for the Veterinary Analgesic

May 31, 2022

Lumosa Therapeutics: Shareholders' Meeting approved to release the company's directors from non-competition restrictions

May 24, 2022

Lumosa Therapeutics: Important resolutions of LUMOSA's 2022 Annual Shareholders' Meeting

May 24, 2022

Board of Directors not to proceed with the private placement of ordinary shares approved by the 2021 annual general meeting of shareholders

Apr 22, 2022

All Lumosa Therapeutics Co Ltd news

Decks

Lumosa Therapeutics Co Ltd on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 17 in all · newest Feb 6, 2026 · oldest 2022
Decks
2 decks · latest May 15, 2026

Log in to ask 6ix AI your own questions about Lumosa Therapeutics Co Ltd.